About this tool
This tool estimates whether a young child who wheezes is likely to have asthma at school age. It is for primary care, pulmonology and allergy clinicians seeing toddlers with recurrent wheeze, when deciding how to label the problem, whether to try a controller and how to follow the child.
Choose one of three tools. The Asthma Predictive Index (API) uses how often the child wheezed in the first 3 years plus major criteria (parental asthma, eczema) and minor criteria (allergic rhinitis, wheeze apart from colds, eosinophils 4% or more); frequent wheeze gives the stringent index, any wheeze the loose index. The modified API needs 4 or more wheezing episodes in a year and adds allergy test results. The Pediatric Asthma Risk Score (PARS) adds points for parental asthma, eczema, early wheeze, wheeze apart from colds, sensitization to 2 or more allergens and African American race (0–14).
The result shows whether the index is positive or the PARS total, how accurate that is in the original studies (odds, positive and negative predictive values), and what to do next: an action plan and reliever for everyone, when a daily or intermittent inhaled corticosteroid trial is reasonable (EPR-3, NAEPP 2020, GINA), why the index alone does not decide treatment (PEAK trial), when to review and when to refer. Sources: Castro-Rodríguez 2000, Guilbert 2004, Chang 2013, Biagini Myers 2019, MacDonald 2022, Guilbert 2006.
Common questions
What is the Asthma Predictive Index?
A rule from the Tucson Children's Respiratory Study for children who wheezed in the first 3 years. It is positive with 1 major criterion (parent with asthma, or eczema in the child) or 2 minor criteria (allergic rhinitis, wheeze apart from colds, eosinophils 4% or more). With frequent early wheeze (stringent index), children had 4.3–9.8 times the odds of active asthma at ages 6–13.
How is the modified API different?
It needs 4 or more wheezing episodes in a year, replaces allergic rhinitis with sensitization to an aeroallergen as a major criterion, and adds sensitization to milk, egg or peanut as a minor criterion. In a high-risk cohort a positive mAPI raised the chance of school-age asthma from about 30% to about 90%.
Does a negative API mean the child will not get asthma?
No. These indexes are better at ruling in than ruling out: sensitivity is low, and a negative modified API lowered the risk only slightly (from 30% to about 26% in a high-risk cohort). Keep reviewing a child who keeps wheezing.
Should a toddler with a positive API get daily inhaled steroids?
Not because of the index alone. Treat according to how often and how badly the child wheezes: EPR-3 and GINA support a trial of daily low-dose inhaled corticosteroid when episodes are frequent or severe, and NAEPP 2020 an intermittent course at the start of colds for wheeze only with infections. In the PEAK trial, two years of daily inhaled steroid controlled symptoms while taken but did not prevent asthma once stopped.